ICON Public Limited Company - Asset Resilience Ratio
ICON Public Limited Company (IJF) has an Asset Resilience Ratio of 0.00% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how liquid is ICON Public Limited Company's working capital to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2024)
This chart shows how ICON Public Limited Company's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see ICON Public Limited Company asset portfolio.
Liquid Assets Composition Over Time
This chart breaks down ICON Public Limited Company's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore IJF long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €0.00 | 0% |
| Total Liquid Assets | €0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: ICON Public Limited Company maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
ICON Public Limited Company Industry Peers by Asset Resilience Ratio
Compare ICON Public Limited Company's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
LONZA GROUP UNSP.ADR 1/10
F:LO3A |
Diagnostics & Research | 3.04% |
|
Lumibird SA
PA:LBIRD |
Diagnostics & Research | 22.85% |
|
INTERGRATED DIA.H DL 025
F:8I8 |
Diagnostics & Research | 7.34% |
|
Bcal Diagnostics Ltd
AU:BDX |
Diagnostics & Research | 0.00% |
|
Check Cap Ltd
NASDAQ:CHEK |
Diagnostics & Research | 70.29% |
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SHG:603882 |
Diagnostics & Research | 0.14% |
|
Sonic Healthcare Ltd
AU:SHL |
Diagnostics & Research | 0.13% |
|
Integral Diagnostics Ltd
AU:IDX |
Diagnostics & Research | 0.03% |
Annual Asset Resilience Ratio for ICON Public Limited Company (2016–2024)
The table below shows the annual Asset Resilience Ratio data for ICON Public Limited Company.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.00% | €0.00 ≈ $0.00 |
€16.88 Billion ≈ $19.73 Billion |
-- |
| 2023-12-31 | 0.01% | €1.95 Million ≈ $2.28 Million |
€16.99 Billion ≈ $19.86 Billion |
+0.00pp |
| 2022-12-31 | 0.01% | €1.71 Million ≈ $2.00 Million |
€17.26 Billion ≈ $20.17 Billion |
+0.00pp |
| 2021-12-31 | 0.01% | €1.71 Million ≈ $2.00 Million |
€17.39 Billion ≈ $20.33 Billion |
-0.04pp |
| 2020-12-31 | 0.05% | €1.73 Million ≈ $2.02 Million |
€3.44 Billion ≈ $4.02 Billion |
-1.66pp |
| 2019-12-31 | 1.71% | €49.63 Million ≈ $58.02 Million |
€2.91 Billion ≈ $3.40 Billion |
-0.84pp |
| 2018-12-31 | 2.54% | €59.91 Million ≈ $70.04 Million |
€2.35 Billion ≈ $2.75 Billion |
-1.07pp |
| 2017-12-31 | 3.61% | €77.59 Million ≈ $90.71 Million |
€2.15 Billion ≈ $2.51 Billion |
-0.11pp |
| 2016-12-31 | 3.73% | €68.05 Million ≈ $79.55 Million |
€1.83 Billion ≈ $2.13 Billion |
-- |
About ICON Public Limited Company
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical stu… Read more